BioCentury
ARTICLE | Clinical News

I-020502: Phase IIa data

August 18, 2008 7:00 AM UTC

One-month follow-up data from a German Phase lla trial in 10 burn patients receiving autologous meshed skin grafts showed that there were no treatment-related adverse events with KUR-212. Patients ser...